Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling

Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Aging cell 2021-10, Vol.20 (10), p.e13480-n/a
Hauptverfasser: Dang, Ruili, Yang, Mengqi, Cui, Changmeng, Wang, Changshui, Zhang, Wenyuan, Geng, Chunmei, Han, Wenxiu, Jiang, Pei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 10
container_start_page e13480
container_title Aging cell
container_volume 20
creator Dang, Ruili
Yang, Mengqi
Cui, Changmeng
Wang, Changshui
Zhang, Wenyuan
Geng, Chunmei
Han, Wenxiu
Jiang, Pei
description Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation. The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome.
doi_str_mv 10.1111/acel.13480
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8520723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2582588551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</originalsourceid><addsrcrecordid>eNp9kkFu1DAUhiMEomVgwwGQJTYFaTq240ycTaXRqAWkkbqBtfXiOBkXxw52MjRd9QhIvRFH6UnwkDIqLLCeZEvv86_fz3-SvCb4lMS1AKnMKUkZx0-SY8JyNi9yunx6OBN-lLwI4Qpjkhc4fZ4cpSyjBefkOPm5kr3eQa-dRa5GYBvtemWDtve3P6SzO-V7bRuk7M3YKkQXjwh0Qu5v7_J3ixYC8kqqrncewbUOqPe6aZQPCIbedVtoxihdoTB0nVchqIBaLb1rjAbUeadtbaBtId4fUecMeH0zedpFoHb-61ZBhUp3jaSBENAlQUE3Fkz09jJ5VoMJ6tXDPku-XJx_Xn-cby4_fFqvNnPJ4mjmlQTGmISU86wqUyjKKiuroqRpkUO1zJksqMJMcsAV5pRgyIuM5Bgqimma4nSWnE263VC2qpLK9h6M6LxuwY_CgRZ_d6zeisbtBM8ozqPELDl5EPDu26BCL1od4t8ZsMoNQdAsZwyz5ZJG9O0_6JUbfHzvnuKxeJaRSL2fqDjKELyqD2YIFvtoiH00xO9oRPjNY_sH9E8WIkAm4Ls2avyPlFitzzeT6C_DocuA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2582588551</pqid></control><display><type>article</type><title>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Dang, Ruili ; Yang, Mengqi ; Cui, Changmeng ; Wang, Changshui ; Zhang, Wenyuan ; Geng, Chunmei ; Han, Wenxiu ; Jiang, Pei</creator><creatorcontrib>Dang, Ruili ; Yang, Mengqi ; Cui, Changmeng ; Wang, Changshui ; Zhang, Wenyuan ; Geng, Chunmei ; Han, Wenxiu ; Jiang, Pei</creatorcontrib><description>Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation. The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome.</description><identifier>ISSN: 1474-9718</identifier><identifier>EISSN: 1474-9726</identifier><identifier>DOI: 10.1111/acel.13480</identifier><identifier>PMID: 34529881</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>ACE2 ; Aging ; Alzheimer's disease ; Angiotensin AT1 receptors ; Angiotensin I - pharmacology ; Angiotensin I - therapeutic use ; Angiotensin II ; Angiotensin-converting enzyme 2 ; Angiotensin-Converting Enzyme 2 - pharmacology ; Angiotensin-Converting Enzyme 2 - therapeutic use ; Animals ; Antioxidants ; Autophagy ; Autophagy - drug effects ; Biomarkers ; Brain research ; Catalase ; Chloroquine ; Cytokines ; Enzymes ; Forkhead protein ; FOXO1 ; FOXO1 protein ; Genotype &amp; phenotype ; Humans ; Immune system ; Inflammasomes ; Inflammation ; Lipopolysaccharides ; Mice ; Microglia ; Microglia - drug effects ; neuroinflammation ; Neuroinflammatory Diseases - drug therapy ; Neuroinflammatory Diseases - genetics ; Neuroprotection ; Original Paper ; Original Papers ; Peptide Fragments - pharmacology ; Peptide Fragments - therapeutic use ; Phagocytosis ; Phenotypes ; Polarization ; Protein expression ; Proteins ; Remission ; Renin ; renin‐angiotensin system ; Signal Transduction ; Superoxide dismutase ; Transfection ; Tumor necrosis factor-TNF</subject><ispartof>Aging cell, 2021-10, Vol.20 (10), p.e13480-n/a</ispartof><rights>2021 The Authors. published by Anatomical Society and John Wiley &amp; Sons Ltd.</rights><rights>2021 The Authors. Aging Cell published by Anatomical Society and John Wiley &amp; Sons Ltd.</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</citedby><cites>FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</cites><orcidid>0000-0002-8360-7427</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520723/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520723/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34529881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dang, Ruili</creatorcontrib><creatorcontrib>Yang, Mengqi</creatorcontrib><creatorcontrib>Cui, Changmeng</creatorcontrib><creatorcontrib>Wang, Changshui</creatorcontrib><creatorcontrib>Zhang, Wenyuan</creatorcontrib><creatorcontrib>Geng, Chunmei</creatorcontrib><creatorcontrib>Han, Wenxiu</creatorcontrib><creatorcontrib>Jiang, Pei</creatorcontrib><title>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</title><title>Aging cell</title><addtitle>Aging Cell</addtitle><description>Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation. The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome.</description><subject>ACE2</subject><subject>Aging</subject><subject>Alzheimer's disease</subject><subject>Angiotensin AT1 receptors</subject><subject>Angiotensin I - pharmacology</subject><subject>Angiotensin I - therapeutic use</subject><subject>Angiotensin II</subject><subject>Angiotensin-converting enzyme 2</subject><subject>Angiotensin-Converting Enzyme 2 - pharmacology</subject><subject>Angiotensin-Converting Enzyme 2 - therapeutic use</subject><subject>Animals</subject><subject>Antioxidants</subject><subject>Autophagy</subject><subject>Autophagy - drug effects</subject><subject>Biomarkers</subject><subject>Brain research</subject><subject>Catalase</subject><subject>Chloroquine</subject><subject>Cytokines</subject><subject>Enzymes</subject><subject>Forkhead protein</subject><subject>FOXO1</subject><subject>FOXO1 protein</subject><subject>Genotype &amp; phenotype</subject><subject>Humans</subject><subject>Immune system</subject><subject>Inflammasomes</subject><subject>Inflammation</subject><subject>Lipopolysaccharides</subject><subject>Mice</subject><subject>Microglia</subject><subject>Microglia - drug effects</subject><subject>neuroinflammation</subject><subject>Neuroinflammatory Diseases - drug therapy</subject><subject>Neuroinflammatory Diseases - genetics</subject><subject>Neuroprotection</subject><subject>Original Paper</subject><subject>Original Papers</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptide Fragments - therapeutic use</subject><subject>Phagocytosis</subject><subject>Phenotypes</subject><subject>Polarization</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Remission</subject><subject>Renin</subject><subject>renin‐angiotensin system</subject><subject>Signal Transduction</subject><subject>Superoxide dismutase</subject><subject>Transfection</subject><subject>Tumor necrosis factor-TNF</subject><issn>1474-9718</issn><issn>1474-9726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp9kkFu1DAUhiMEomVgwwGQJTYFaTq240ycTaXRqAWkkbqBtfXiOBkXxw52MjRd9QhIvRFH6UnwkDIqLLCeZEvv86_fz3-SvCb4lMS1AKnMKUkZx0-SY8JyNi9yunx6OBN-lLwI4Qpjkhc4fZ4cpSyjBefkOPm5kr3eQa-dRa5GYBvtemWDtve3P6SzO-V7bRuk7M3YKkQXjwh0Qu5v7_J3ixYC8kqqrncewbUOqPe6aZQPCIbedVtoxihdoTB0nVchqIBaLb1rjAbUeadtbaBtId4fUecMeH0zedpFoHb-61ZBhUp3jaSBENAlQUE3Fkz09jJ5VoMJ6tXDPku-XJx_Xn-cby4_fFqvNnPJ4mjmlQTGmISU86wqUyjKKiuroqRpkUO1zJksqMJMcsAV5pRgyIuM5Bgqimma4nSWnE263VC2qpLK9h6M6LxuwY_CgRZ_d6zeisbtBM8ozqPELDl5EPDu26BCL1od4t8ZsMoNQdAsZwyz5ZJG9O0_6JUbfHzvnuKxeJaRSL2fqDjKELyqD2YIFvtoiH00xO9oRPjNY_sH9E8WIkAm4Ls2avyPlFitzzeT6C_DocuA</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Dang, Ruili</creator><creator>Yang, Mengqi</creator><creator>Cui, Changmeng</creator><creator>Wang, Changshui</creator><creator>Zhang, Wenyuan</creator><creator>Geng, Chunmei</creator><creator>Han, Wenxiu</creator><creator>Jiang, Pei</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8360-7427</orcidid></search><sort><creationdate>202110</creationdate><title>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</title><author>Dang, Ruili ; Yang, Mengqi ; Cui, Changmeng ; Wang, Changshui ; Zhang, Wenyuan ; Geng, Chunmei ; Han, Wenxiu ; Jiang, Pei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4480-dca444ca3885db3a9bd5bd9b2397ad674c92e04c8a0d08210a795170ad2023303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>ACE2</topic><topic>Aging</topic><topic>Alzheimer's disease</topic><topic>Angiotensin AT1 receptors</topic><topic>Angiotensin I - pharmacology</topic><topic>Angiotensin I - therapeutic use</topic><topic>Angiotensin II</topic><topic>Angiotensin-converting enzyme 2</topic><topic>Angiotensin-Converting Enzyme 2 - pharmacology</topic><topic>Angiotensin-Converting Enzyme 2 - therapeutic use</topic><topic>Animals</topic><topic>Antioxidants</topic><topic>Autophagy</topic><topic>Autophagy - drug effects</topic><topic>Biomarkers</topic><topic>Brain research</topic><topic>Catalase</topic><topic>Chloroquine</topic><topic>Cytokines</topic><topic>Enzymes</topic><topic>Forkhead protein</topic><topic>FOXO1</topic><topic>FOXO1 protein</topic><topic>Genotype &amp; phenotype</topic><topic>Humans</topic><topic>Immune system</topic><topic>Inflammasomes</topic><topic>Inflammation</topic><topic>Lipopolysaccharides</topic><topic>Mice</topic><topic>Microglia</topic><topic>Microglia - drug effects</topic><topic>neuroinflammation</topic><topic>Neuroinflammatory Diseases - drug therapy</topic><topic>Neuroinflammatory Diseases - genetics</topic><topic>Neuroprotection</topic><topic>Original Paper</topic><topic>Original Papers</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptide Fragments - therapeutic use</topic><topic>Phagocytosis</topic><topic>Phenotypes</topic><topic>Polarization</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Remission</topic><topic>Renin</topic><topic>renin‐angiotensin system</topic><topic>Signal Transduction</topic><topic>Superoxide dismutase</topic><topic>Transfection</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dang, Ruili</creatorcontrib><creatorcontrib>Yang, Mengqi</creatorcontrib><creatorcontrib>Cui, Changmeng</creatorcontrib><creatorcontrib>Wang, Changshui</creatorcontrib><creatorcontrib>Zhang, Wenyuan</creatorcontrib><creatorcontrib>Geng, Chunmei</creatorcontrib><creatorcontrib>Han, Wenxiu</creatorcontrib><creatorcontrib>Jiang, Pei</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dang, Ruili</au><au>Yang, Mengqi</au><au>Cui, Changmeng</au><au>Wang, Changshui</au><au>Zhang, Wenyuan</au><au>Geng, Chunmei</au><au>Han, Wenxiu</au><au>Jiang, Pei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling</atitle><jtitle>Aging cell</jtitle><addtitle>Aging Cell</addtitle><date>2021-10</date><risdate>2021</risdate><volume>20</volume><issue>10</issue><spage>e13480</spage><epage>n/a</epage><pages>e13480-n/a</pages><issn>1474-9718</issn><eissn>1474-9726</eissn><abstract>Brain renin‐angiotensin (Ang) system (RAS) is implicated in neuroinflammation, a major characteristic of aging process. Angiotensin (Ang) II, produced by angiotensin‐converting enzyme (ACE), activates immune system via angiotensin type 1 receptor (AT1), whereas Ang(1–7), generated by ACE2, binds with Mas receptor (MasR) to restrain excessive inflammatory response. Therefore, the present study aims to explore the relationship between RAS and neuroinflammation. We found that repeated lipopolysaccharide (LPS) treatment shifted the balance between ACE/Ang II/AT1 and ACE2/Ang(1–7)/MasR axis to the deleterious side and treatment with either MasR agonist, AVE0991 (AVE) or ACE2 activator, diminazene aceturate, exhibited strong neuroprotective actions. Mechanically, activation of ACE2/Ang(1–7)/MasR axis triggered the Forkhead box class O1 (FOXO1)‐autophagy pathway and induced superoxide dismutase (SOD) and catalase (CAT), the FOXO1‐targeted antioxidant enzymes. Meanwhile, knockdown of MasR or FOXO1 in BV2 cells, or using the selective FOXO1 inhibitor, AS1842856, in animals, suppressed FOXO1 translocation and compromised the autophagic process induced by MasR activation. We further used chloroquine (CQ) to block autophagy and showed that suppressing either FOXO1 or autophagy abrogated the anti‐inflammatory action of AVE. Likewise, Ang(1–7) also induced FOXO1 signaling and autophagic flux following LPS treatment in BV2 cells. Cotreatment with AS1842856 or CQ all led to autophagic inhibition and thereby abolished Ang(1–7)‐induced remission on NLRP3 inflammasome activation caused by LPS exposure, shifting the microglial polarization from M1 to M2 phenotype. Collectively, these results firstly illustrated the mechanism of ACE2/Ang(1–7)/MasR axis in neuroinflammation, strongly indicating the involvement of FOXO1‐mediated autophagy in the neuroimmune‐modulating effects triggered by MasR activation. The neuroimmune‐regulatory mechanism of ACE2/Ang(1–7)/MasR axis. ACE2 cleaves AngII into Ang(1–7), which than binds with MasR. The activation of MasR triggers FOXO1 translocation and induces autophagic process, thereby accelerating the clearance of NLRP3 inflammasome.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>34529881</pmid><doi>10.1111/acel.13480</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0002-8360-7427</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1474-9718
ispartof Aging cell, 2021-10, Vol.20 (10), p.e13480-n/a
issn 1474-9718
1474-9726
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8520723
source MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects ACE2
Aging
Alzheimer's disease
Angiotensin AT1 receptors
Angiotensin I - pharmacology
Angiotensin I - therapeutic use
Angiotensin II
Angiotensin-converting enzyme 2
Angiotensin-Converting Enzyme 2 - pharmacology
Angiotensin-Converting Enzyme 2 - therapeutic use
Animals
Antioxidants
Autophagy
Autophagy - drug effects
Biomarkers
Brain research
Catalase
Chloroquine
Cytokines
Enzymes
Forkhead protein
FOXO1
FOXO1 protein
Genotype & phenotype
Humans
Immune system
Inflammasomes
Inflammation
Lipopolysaccharides
Mice
Microglia
Microglia - drug effects
neuroinflammation
Neuroinflammatory Diseases - drug therapy
Neuroinflammatory Diseases - genetics
Neuroprotection
Original Paper
Original Papers
Peptide Fragments - pharmacology
Peptide Fragments - therapeutic use
Phagocytosis
Phenotypes
Polarization
Protein expression
Proteins
Remission
Renin
renin‐angiotensin system
Signal Transduction
Superoxide dismutase
Transfection
Tumor necrosis factor-TNF
title Activation of angiotensin‐converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A35%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20angiotensin%E2%80%90converting%20enzyme%202/angiotensin%20(1%E2%80%937)/mas%20receptor%20axis%20triggers%20autophagy%20and%20suppresses%20microglia%20proinflammatory%20polarization%20via%20forkhead%20box%20class%20O1%20signaling&rft.jtitle=Aging%20cell&rft.au=Dang,%20Ruili&rft.date=2021-10&rft.volume=20&rft.issue=10&rft.spage=e13480&rft.epage=n/a&rft.pages=e13480-n/a&rft.issn=1474-9718&rft.eissn=1474-9726&rft_id=info:doi/10.1111/acel.13480&rft_dat=%3Cproquest_pubme%3E2582588551%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2582588551&rft_id=info:pmid/34529881&rfr_iscdi=true